
Hims & Hers Health, Inc.
HIMS
$25.41
per share, on-chain
What Hims & Hers Health does
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
- Industry
- Healthcare
- CEO
- Andrew Dudum
- Website
- forhims.com
Ways to own Hims & Hers Health, Inc.
There are 2 versions of this stock. Same company; they differ in cost and in when they trade.
bStocksHIMSBOur pick
Trades around the clock, from $1.
Backing is reported by Binance. A public report link isn't available yet.
$25.41
Open 24/7OndoHIMSon
Wider choice. Usually $20 minimum, and it can cost more when New York is closed.
Daily backing report (29 Oct) ↗Monthly backing report (Sep 2026) ↗
$25.39
Open, outside US hours
Price check
What a slice looks like
$10.00 buys you 0.39 of one Hims & Hers Health share.
That's 39.4% of one share. Small, but it's yours, and it moves with the real price. One share costs $25.41.